Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06881407 · ClinicalTrials.gov registry record · NA

Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial

A NA study of Cerebral Palsy (CP), sponsored by Georgia State University.

Recruiting
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT06881407: Recruiting NA study of Cerebral Palsy (CP), sponsored by Georgia State University.

NCT06881407 is a NA study of Cerebral Palsy (CP) that is actively recruiting participants, run by Georgia State University. The registered enrollment target is 42 participants, above the 24-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (75% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06881407, a NA study of Cerebral Palsy (CP), is actively recruiting participants, sponsored by Georgia State University.

RECRUITING
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

About 60% of children with cerebral palsy (CP) have impaired arm function. Improving arm function requires hundreds of repetitions per day, which is impossible in a single clinical visit. Thus, therapeutic exercises should be sustained in the home environment; however, the compliance in performing home exercise is low due to poor motivation, boredom, and forgetfulness. A better home program is needed. The objective of this project is to examine the effect of our developed "THRIVE" system (Therapeutic Humanoid Robot In Virtual Environment: the combination of robot with virtual reality games), which can provide a motivating and tailored upper-extremity intervention program with instant feedback, to improve arm function in children with CP at their home. The investigators believe the newly developed "THRIVE" system can increase children's engagement and motivation in home exercises as the robot is their playmate to demonstrate and correct their movements. The investigators will also interview parents and children with CP to understand their impression of using technology at home to shape the intervention. The expected outcome is that children with CP receiving "THRIVE" will improve their arm function more and have better engagement than those who receive VR alone immediately after intervention and at follow-up. The long-term goal is to have the "THRIVE" system be the optimal home exercise platform as it can provide challenging but motivating exercises to improve children's arm function while assisting parents in supervising their children with CP to complete home exercises.

Primary Outcome

Reaching kinematics will be assessed while the child is interacting with Super Pop VR, wherein virtual bubbles are projected onto the standard projecting screen in randomly dispersed locations using the Kinect system. Three testing bubbles will be situated in the location where children need to reach about arm length overhead at 180°, 135°, and 90° of shoulder abduction, with instructions for children to reach in two conditions: (1) as fast as possible and (2) as accurate as possible. Children's

Conditions Studied

Interventions

  • DEVICE Virtual Reality
  • DEVICE Robot

Study Locations (1)

Georgia

  • Department of Physical Therapy, Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2025-02-25
Est. Completion 2027-08-31
Phase NA
Georgia State University

45 total trials

What NCT06881407 shows while recruiting

NCT06881407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, above the 24-participant average among 7 other Cerebral Palsy (CP) trials with a reported enrollment target (75% higher).

The record links to 1 condition, with Cerebral Palsy (CP) appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality is the first listed.

NCT06881407 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06881407 about?

NCT06881407 is a clinical study titled "Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial". About 60% of children with cerebral palsy (CP) have impaired arm function. Improving arm function requires hundreds of repetitions per day, which is impossible in a single clinical visit. Thus, therapeutic exercises should be sustained in the home environment; however, the compliance in performing h...

What is the current status of trial NCT06881407?

This trial is currently recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2025-02-25. Estimated completion is 2027-08-31.

What conditions does trial NCT06881407 study?

This clinical trial studies the following conditions: Cerebral Palsy (CP).

What interventions are being tested in trial NCT06881407?

The interventions under investigation include: Virtual Reality (DEVICE), Robot (DEVICE).

Who is sponsoring clinical trial NCT06881407?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06881407 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy (CP)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06881407, the US trial registry maintained by the National Library of Medicine. NCT06881407 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.